WallStreetZenWallStreetZen

NASDAQ: APGE
Apogee Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Apogee Therapeutics earnings were -$274.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest APGE earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$74.1M, up 6.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, APGE reported annual earnings of -$255.8M, with 40.5% growth.

APGE earnings history

Current Revenue
$0.0
Current Earnings
-$274.6M
Current Profit Margin
0%

APGE Return on Equity

Current Company
-32.6%
Current Industry
-143.8%
Current Market
5.2%
APGE's Return on Equity (-32.6%)... subscribe to Premium to read more.
High Return on Equity Performance

APGE Return on Assets

Current Company
-31.3%
Current Industry
-10.8%
APGE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when APGE announces earnings.

APGE Return on Capital Employed

Current Company
-21.76%
Current Industry
-6.9%
APGE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

APGE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
APGE-$268.92M-$274.62MN/A-$4.33
RYTM-$180.75M-$207.84MN/A-$3.13
PTCT-$14.06M-$186.73MN/A-$2.48
CGON-$184.42M-$186.75MN/A-$2.33
CNTA-$237.11M-$250.64MN/A-$1.79
View Top Biotech Stocks

Apogee Therapeutics Earnings Reports & History FAQ

What were Apogee Therapeutics's earnings last quarter?

Apogee Therapeutics (NASDAQ: APGE) reported Q1 2026 earnings per share (EPS) of -$1.06, up 11.58% year over year. Total APGE earnings for the quarter were -$74.11 million. In the same quarter last year, Apogee Therapeutics's earnings per share (EPS) was -$0.95.

If you're new to stock investing, here's how to buy Apogee Therapeutics stock.

Is Apogee Therapeutics profitable or losing money?

As of the last Apogee Therapeutics earnings report, Apogee Therapeutics is currently losing money. Apogee Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$274.62 million, a 33.7% increase year over year.

What was APGE's earnings growth in the past year?

As of Apogee Therapeutics's earnings date in Q2 2026, Apogee Therapeutics's earnings has grown year over year. APGE earnings in the past year totalled -$274.62 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.